Jefferies Maintains a 'Hold' on Intuit (INTU); Consumer Tax and Lower Opex Drives Upside
Tweet
Share
E-mailGet Alerts INTU Hot Sheet
Price: $361.87 -0.17%
Rating Summary:
31 Buy, 12 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
31 Buy, 12 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Jefferies maintains a 'Hold' on Intuit (NASDAQ: INTU) price target raised from $55 to $58.
Jefferies analyst says, "We remain a Hold on INTU because, despite signs of improving conditions for the SMB business and solid margin expansion, we think Consumer Tax faces the challenge of a smaller shift from manual, no price changes, flat aggregate returns and more aggressive competition. Consumer Tax unit growth of +10% STD through 2/18/12 was a bit lower than we expected given the comps and unit growth needs to be maintained, despite tougher comps through season end."
Jefferies raises FY13 EPS estimate from $3.30 to $3.34 and FY14 from $3.66 to $3.76.
For an analyst ratings summary and ratings history on Intuit click here. For more ratings news on Intuit click here.
Shares of Intuit closed at $57.52 yesterday.
Jefferies analyst says, "We remain a Hold on INTU because, despite signs of improving conditions for the SMB business and solid margin expansion, we think Consumer Tax faces the challenge of a smaller shift from manual, no price changes, flat aggregate returns and more aggressive competition. Consumer Tax unit growth of +10% STD through 2/18/12 was a bit lower than we expected given the comps and unit growth needs to be maintained, despite tougher comps through season end."
Jefferies raises FY13 EPS estimate from $3.30 to $3.34 and FY14 from $3.66 to $3.76.
For an analyst ratings summary and ratings history on Intuit click here. For more ratings news on Intuit click here.
Shares of Intuit closed at $57.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
- Oppenheimer Reiterates Outperform Rating on NVIDIA (NVDA) Into EPS
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
